Measurement of the Walking Duration With Therapeutic Shoes in Neuropathic Diabetic Patients by a Novel Device (Show-me)
- Thomas Kästenbauer, PHD12,
- Johann Wassermann, PHD3,
- Elisabeth Krippl, MD4,
- Rudolf Prager, MD14 and
- Karl Irsigler, MD2
- 1Karl Landsteiner Institute of Metabolic Diseases and Nephrology, Hospital Hietzing, Vienna, Austria
- 2Ludwig Boltzmann Institute of Metabolic Diseases and Nutrition, Hospital Hietzing, Vienna, Austria
- 3Institute for Mechanics and Mechatronics, Vienna University of Technology, Vienna, Austria
- 4Third Medical Department of Metabolic Diseases and Nephrology, Hospital Hietzing, Vienna, Austria
- Address correspondence to Thomas Kästenbauer, MSc, PhD, Karl Landsteiner Institute of Metabolic Diseases and Nephrology, Hospital Hietzing, Wolkersbergenstrasse 1, A-1130 Vienna, Austria. E-mail: thomas.kaestenbauer{at}wienkav.at
Therapeutic shoes and other prophylactic interventions are used to prevent diabetic foot ulceration (1,2), but patient’s compliance to use prescribed footwear has never been investigated in primary care. Therapeutic footwear might be effective in secondary ulcer prevention, as demonstrated in two noncontrolled trials, but was only effective when worn >60% of the daytime (3) or >8 h a day (4). In a controlled clinical trial, no benefit was observed between control patients wearing their own footwear and intervention patients wearing specialized footwear (5).
The aim was to measure the duration of walking with therapeutic shoes by a novel device, “Show-me” (shoe-wearing measuring equipment), in neuropathic patients without a history of …
